Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018068020) PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/068020 International Application No.: PCT/US2017/055659
Publication Date: 12.04.2018 International Filing Date: 06.10.2017
IPC:
G01N 33/574 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
574
for cancer
Applicants:
DISCERNDX, INC. [US/US]; 2478 Embarcadero Way Palo Alto, California 94303, US
Inventors:
BLUME, John; US
KAO, Athit; US
DILLON, Roslyn; US
CRONER, Lisa; US
WILCOX, Bruce; US
Agent:
ANDERSON, Garrett H.; US
Priority Data:
15/414,45624.01.2017US
62/405,77107.10.2016US
Title (EN) PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
(FR) PANELS DE BIOMARQUEURS PROTÉIQUES POUR LA DÉTECTION D'UN CANCER COLORECTAL ET D'UN ADÉNOME AVANCÉ
Abstract:
(EN) Disclosed herein are panels related to the diagnosis or recognition of advanced adenoma and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report for clinical management.
(FR) La présente invention concerne des panels se rapportant au diagnostic ou à la reconnaissance d'un adénome avancé et d'un cancer colorectal chez un sujet. Les panels et les procédés associés selon l'invention sont utilisés pour prédire ou évaluer l'état d'une tumeur du côlon chez un patient. Ils peuvent être utilisés pour déterminer la nature d'une tumeur, une récidive ou la réponse du patient à des traitements. Certains modes de réalisation des procédés comprennent la génération d'un rapport pour la gestion clinique.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)